Form 3 - Initial statement of beneficial ownership of securities

US Tech 100

21,189.60

1.30%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 3 - Initial statement of beneficial ownership of securities

NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Jan 2025 to Feb 2025

NovoCure (NASDAQ:NVCR)
Historical Stock Chart
From Feb 2024 to Feb 2025

NovoCure Ltd News

Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
Wednesday 22 January 2025 (3 weeks ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 15 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
Monday 13 January 2025 (4 weeks ago) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Monday 6 January 2025 (1 month ago) • Edgar (US Regulatory)

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Friday 3 January 2025 (1 month ago) • Business Wire

Novocure gibt positive Ergebnisse der Phase-3-Studie PANOVA-3 zur Tumor Treating Fields (TTFields)-Therapie bei Bauchspeicheldrüsenkrebs bekannt
Thursday 5 December 2024 (2 months ago) • Business Wire

ノボキュア、膵がんに対する腫瘍治療電場療法（TTフィールド）の第3相臨床試験PANOVA-3のトップライン結果を発表
Wednesday 4 December 2024 (2 months ago) • Business Wire

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Monday 2 December 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Monday 2 December 2024 (2 months ago) • Edgar (US Regulatory)

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
Monday 2 December 2024 (2 months ago) • Business Wire

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

NVCR NovoCure Ltd

NovoCure Ltd News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

NVCR NovoCure Ltd

NovoCure Ltd News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free